Literature DB >> 8267637

Activin A induces apoptotic cell death.

T Nishihara1, N Okahashi, N Ueda.   

Abstract

Activins, members of a family of the transforming growth factor beta (TGF beta), are involved in the regulation of multiple biological events. We found a novel effect of activin A on hybridoma and myeloma cell lines. Activin A exhibited a cytotoxic effect on interleukin-6 (IL-6)-dependent B9 cells and induced a significant increase in the proportion of fragmented DNA. B9 cells exposed to activin A released high amounts of lactate dehydrogenase (LDH) and exhibited the typical ladder pattern of DNA fragmentation of apoptotic cells. IL-6 did not prevent apoptosis of B9 cells induced by activin A. The cytotoxicity of activin A to B9 cells was suppressed by follistatin. On the other hand, TGF beta showed no cytotoxic effect on B9 cells. These findings indicate that apoptosis induced by activin A could be one of the mechanisms to prevent uncontrolled cell growth.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8267637     DOI: 10.1006/bbrc.1993.2576

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Activin A binds to perlecan through its pro-region that has heparin/heparan sulfate binding activity.

Authors:  Shaoliang Li; Chisei Shimono; Naoko Norioka; Itsuko Nakano; Tetsuo Okubo; Yoshiko Yagi; Maria Hayashi; Yuya Sato; Hitomi Fujisaki; Shunji Hattori; Nobuo Sugiura; Koji Kimata; Kiyotoshi Sekiguchi
Journal:  J Biol Chem       Date:  2010-09-15       Impact factor: 5.157

2.  Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies.

Authors:  E W Yu; K E Dolter; L E Shao; J Yu
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

3.  Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo.

Authors:  J E Pawlowski; D S Taylor; M Valentine; M E Hail; P Ferrer; M C Kowala; C J Molloy
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

4.  Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.

Authors:  F Itoh; H Asao; K Sugamura; C H Heldin; P ten Dijke; S Itoh
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

5.  Gene expression profiling reveals Cyp26b1 to be an activin regulated gene involved in ovarian granulosa cell proliferation.

Authors:  Jingjing L Kipp; Ann Golebiowski; Guadalupe Rodriguez; Michael Demczuk; Signe M Kilen; Kelly E Mayo
Journal:  Endocrinology       Date:  2010-11-17       Impact factor: 4.736

6.  The rasGAP-binding protein, Dok-1, mediates activin signaling via serine/threonine kinase receptors.

Authors:  Norio Yamakawa; Kunihiro Tsuchida; Hiromu Sugino
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

7.  Interleukin-1 beta enhances and interferon-gamma suppresses activin A actions by reciprocally regulating activin A and follistatin secretion from bone marrow stromal fibroblasts.

Authors:  M Abe; Y Shintani; Y Eto; K Harada; Y Fujinaka; M Kosaka; T Matsumoto
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

8.  Upregulation of activin signaling in experimental colitis.

Authors:  You-Qing Zhang; Silvia Resta; Barbara Jung; Kim E Barrett; Nora Sarvetnick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-07-30       Impact factor: 4.052

9.  Effect of keratinocyte growth factor and activin on cell growth in the human prostatic cancer cell line LNCaP.

Authors:  Bernhard Planz; Horia Oltean; Thomas Deix; Sandra D Kirley; Qi Fa Wang; W S McDougal; Michael Marberger
Journal:  World J Urol       Date:  2004-02-27       Impact factor: 4.226

10.  Follistatin is a novel biomarker for lung adenocarcinoma in humans.

Authors:  Fangfang Chen; Ping Ren; Ye Feng; Haiyan Liu; Yang Sun; Zhonghui Liu; Jingyan Ge; Xueling Cui
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.